Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iAPA-DC/CTL Combined with Gemcitabine in Advanced Pancreatic Cancer
NCT02529579Phase 2Unknown
- Sponsor
- Changhai Hospital
- Start
- Jun 2015
- Primary completion
- Dec 2018
- Modality
- Whole Cell Cancer Vaccines, Cytokines & Interferons, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of iAPA-DC + CTL in pancreatic ductal adenocarcinoma (PDAC), sponsored by Changhai Hospital. Status: unknown.
02
Drugs
iAPA-DC + CTL
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02529579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529579.